ELITE UNIVERSAL TEST BANK: EGAN’S
FUNDAMENTALS OF RESPIRATORY
CARE (13TH ED.)
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Testing "Hard Deck"
definitions, core formulas, 2024–2026 AARC/GOLD/GINA guidelines, and E-Medicine
architecture.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Patient-Ventilator
Interactions (Chapter 48), Cardiopulmonary Calculations, and Pharmacological Titration.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-stakes clinical simulations,
mixed-pathology triage, advanced hemodynamics, and failure-aversion algorithms.
PART I: THE PRIMER
Mastering this specific test bank translates directly to elite clinical competence by replacing rote
memorization with dynamic, algorithmic decision-making. These rigorously vetted scenarios
forge practitioners capable of flawless execution under extreme cognitive load, setting the global
standard for advanced respiratory care.
● The "Critical Axioms" Cheat Sheet:
○ Lung-Protective Hard Deck (AARC 2024): Always maintain tidal volumes at 4–8
mL/kg of predicted body weight and rigidly assess plateau pressures to prevent
ventilator-induced lung injury (VILI). Continuous cuff pressure monitoring is not
recommended solely to decrease VAP risk.
○ The Liberation Protocol (AARC 2024): The Rapid Shallow Breathing Index
(RSBI) is no longer required to determine Spontaneous Breathing Trial (SBT)
readiness. Conduct standardized SBTs before noon, and never increase the
fractional inspired oxygen (FiO2) during the trial.
○ Pediatric Critical Asthma (AARC 2025): Implement continuous inhaled
short-acting beta-agonists (SABA) over intermittent dosing. Intravenous magnesium
is the preferred adjunct; intravenous methylxanthines are no longer recommended.
○ GOLD 2026 Escalation: Escalate COPD maintenance therapy after a single
moderate exacerbation. The clinical objective is a "low disease activity state"
characterized by absolute zero exacerbations.
○ GINA 2025 Track 1 (MART): Low-dose ICS-formoterol is the globally preferred
reliever and maintenance therapy across all asthma steps to neutralize underlying
inflammation and prevent severe exacerbations.
○ The Synchrony Law (Egan's Ch. 48): Treat asynchrony by treating the patient, not
, just the machine. Manage auto-PEEP by increasing expiratory time, elevating flow
cycle-off, or clearing airway resistance.
Core Cardiopulmonary Formula Elite Application
Equation
Alveolar Gas Equation $ - (PaCO_.8)$ Isolates alveolar oxygen to
(PAO2) detect hidden anatomical
shunts via the A-a gradient.
Desired FiO2 (Desired PaO_2 \times Current Prevents oxygen toxicity by
FiO_2) / Current PaO_2 calculating the exact fractional
requirement.
Airway Resistance (Raw) (PIP - Pplat) / Flow (L/sec) Differentiates bronchospasm
from decreased lung
compliance.
Desired Minute Ventilation (Current V_E \times Current Precisely corrects
PaCO_2) / Desired PaCO_2 uncompensated respiratory
acidosis.
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: An adult patient with Acute Respiratory Distress Syndrome (ARDS) is initiated on invasive
mechanical ventilation. Based on the 2024 AARC Clinical Practice Guideline for
Patient-Ventilator Assessment, which action regarding tidal volume (VT) delivery is the MOST
ACCURATE? A) Deliver 8–10 mL/kg based on the patient's actual body weight to prevent
atelectrauma. B) Assess and deliver 4–8 mL/kg based on predicted body weight and
continuously assess cuff pressure to prevent VAP. C) Assess and deliver 4–8 mL/kg based on
predicted body weight, utilizing a manometer for intermittent cuff pressure assessment. D)
Deliver 6–8 mL/kg based on ideal body weight, utilizing telemonitoring exclusively to minimize
room entries.
● The Answer: C (Assess and deliver 4–8 mL/kg based on predicted body weight, utilizing a
manometer for intermittent cuff pressure assessment)
● Distractor Analysis:
○ A is incorrect: Using actual body weight in ARDS delivers massive, lethal volumes
leading to volutrauma, as lung size scales with height, not adiposity.
○ B is incorrect: While the VT parameters are correct, the 2024 AARC CPG explicitly
states that continuous cuff pressure assessment should NOT be implemented to
decrease the risk of Ventilator-Associated Pneumonia (VAP).
○ D is incorrect: The guidelines recommend direct bedside assessment rather than
telemonitoring when resources are adequate; telemonitoring is a supplement, not
an exclusive replacement.
The Mentor's Analysis: Lung-protective ventilation requires strict adherence to predicted body
weight formulas to bypass the common novice error of over-ventilating obese patients.
Furthermore, routine intermittent manometer checks remain the evidence-based standard over
continuous cuff monitors. Professional/Academic Intuition: Always scale VT to height via
predicted body weight, and abandon continuous cuff monitoring if the sole goal is VAP
reduction.
Q2: A 65-year-old mechanically ventilated patient is being evaluated for ventilator liberation. The
, attending physician requests a Rapid Shallow Breathing Index (RSBI) calculation before
initiating a Spontaneous Breathing Trial (SBT). According to the 2024 AARC CPG on SBTs,
what is the MOST APPROPRIATE response? A) Calculate the RSBI; if the value is less than
105, immediately initiate the SBT on continuous positive airway pressure (CPAP). B) Inform the
physician that RSBI calculation is not needed to determine SBT readiness, and initiate the SBT
using a standardized protocol. C) Calculate the RSBI and simultaneously increase the FiO2 by
10% to ensure adequate oxygenation during the transition. D) Delay the SBT until the late
afternoon to ensure the patient's neurocognitive status is optimal, bypassing the RSBI entirely.
● The Answer: B (Inform the physician that RSBI calculation is not needed to determine
SBT readiness, and initiate the SBT using a standardized protocol)
● Distractor Analysis:
○ A is incorrect: Relying on the legacy RSBI threshold (105) is an outdated
methodology; the 2024 guidelines definitively state RSBI calculation is no longer
necessary to dictate readiness.
○ C is incorrect: The 2024 AARC CPG explicitly mandates that FiO2 should NOT be
increased during an SBT, as this masks borderline pulmonary failure.
○ D is incorrect: The guidelines specifically suggest a standardized approach to
assessment and completion of an SBT before noon each day, not in the afternoon.
The Mentor's Analysis: The liberation phase demonstrates physiologic reserve, not the ability to
pass an isolated mathematical index. By abandoning the mandatory RSBI and refusing to
artificially inflate oxygen parameters, the clinician exposes the true ventilatory capacity of the
patient. Professional/Academic Intuition: Assess readiness early (before noon), eliminate the
RSBI prerequisite, and never artificially prop up oxygenation during a trial.
Q3: A 7-year-old child is admitted to the pediatric intensive care unit with status asthmaticus.
Based on the 2025 AARC/PALISI Clinical Practice Guideline for Pediatric Critical Asthma, which
initial pharmacological intervention is the MOST ACCURATE? A) Intermittent high-dose
nebulized short-acting beta-agonists (SABA) combined with intravenous methylxanthines. B)
Continuous inhaled SABA therapy and intravenous magnesium. C) Frequent intermittent SABA
therapy and application of heliox to bypass airway resistance. D) Continuous inhaled SABA
therapy and high-flow nasal cannula (HFNC) specifically to resolve impending hypercapnia.
● The Answer: B (Continuous inhaled SABA therapy and intravenous magnesium)
● Distractor Analysis:
○ A is incorrect: The 2025 guidelines cannot recommend for or against IV
methylxanthines; they represent a legacy theory largely abandoned due to narrow
therapeutic indices and high toxicity.
○ C is incorrect: Continuous SABA is heavily preferred over intermittent delivery.
Furthermore, the guideline cannot recommend for or against the use of heliox.
○ D is incorrect: HFNC provides oxygenation but does not reliably resolve
hypercapnia in critical asthma, and there is insufficient evidence to recommend
BiPAP over HFNC for pure distress.
The Mentor's Analysis: Pediatric critical asthma requires rapid, sustained bronchodilation and
smooth muscle relaxation. Continuous SABA paired with the calcium-channel blocking
properties of IV magnesium delivers a superior dual-mechanism approach to refractory
bronchospasm. Professional/Academic Intuition: In pediatric critical asthma, continuous
nebulization supersedes intermittent dosing, and IV magnesium is the supreme adjunct
over outdated methylxanthines.
Q4: A 62-year-old male with a history of COPD is evaluated in the pulmonary clinic. He reports
one moderate exacerbation in the past 11 months that required systemic corticosteroids, but no
FUNDAMENTALS OF RESPIRATORY
CARE (13TH ED.)
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Testing "Hard Deck"
definitions, core formulas, 2024–2026 AARC/GOLD/GINA guidelines, and E-Medicine
architecture.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Patient-Ventilator
Interactions (Chapter 48), Cardiopulmonary Calculations, and Pharmacological Titration.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-stakes clinical simulations,
mixed-pathology triage, advanced hemodynamics, and failure-aversion algorithms.
PART I: THE PRIMER
Mastering this specific test bank translates directly to elite clinical competence by replacing rote
memorization with dynamic, algorithmic decision-making. These rigorously vetted scenarios
forge practitioners capable of flawless execution under extreme cognitive load, setting the global
standard for advanced respiratory care.
● The "Critical Axioms" Cheat Sheet:
○ Lung-Protective Hard Deck (AARC 2024): Always maintain tidal volumes at 4–8
mL/kg of predicted body weight and rigidly assess plateau pressures to prevent
ventilator-induced lung injury (VILI). Continuous cuff pressure monitoring is not
recommended solely to decrease VAP risk.
○ The Liberation Protocol (AARC 2024): The Rapid Shallow Breathing Index
(RSBI) is no longer required to determine Spontaneous Breathing Trial (SBT)
readiness. Conduct standardized SBTs before noon, and never increase the
fractional inspired oxygen (FiO2) during the trial.
○ Pediatric Critical Asthma (AARC 2025): Implement continuous inhaled
short-acting beta-agonists (SABA) over intermittent dosing. Intravenous magnesium
is the preferred adjunct; intravenous methylxanthines are no longer recommended.
○ GOLD 2026 Escalation: Escalate COPD maintenance therapy after a single
moderate exacerbation. The clinical objective is a "low disease activity state"
characterized by absolute zero exacerbations.
○ GINA 2025 Track 1 (MART): Low-dose ICS-formoterol is the globally preferred
reliever and maintenance therapy across all asthma steps to neutralize underlying
inflammation and prevent severe exacerbations.
○ The Synchrony Law (Egan's Ch. 48): Treat asynchrony by treating the patient, not
, just the machine. Manage auto-PEEP by increasing expiratory time, elevating flow
cycle-off, or clearing airway resistance.
Core Cardiopulmonary Formula Elite Application
Equation
Alveolar Gas Equation $ - (PaCO_.8)$ Isolates alveolar oxygen to
(PAO2) detect hidden anatomical
shunts via the A-a gradient.
Desired FiO2 (Desired PaO_2 \times Current Prevents oxygen toxicity by
FiO_2) / Current PaO_2 calculating the exact fractional
requirement.
Airway Resistance (Raw) (PIP - Pplat) / Flow (L/sec) Differentiates bronchospasm
from decreased lung
compliance.
Desired Minute Ventilation (Current V_E \times Current Precisely corrects
PaCO_2) / Desired PaCO_2 uncompensated respiratory
acidosis.
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: An adult patient with Acute Respiratory Distress Syndrome (ARDS) is initiated on invasive
mechanical ventilation. Based on the 2024 AARC Clinical Practice Guideline for
Patient-Ventilator Assessment, which action regarding tidal volume (VT) delivery is the MOST
ACCURATE? A) Deliver 8–10 mL/kg based on the patient's actual body weight to prevent
atelectrauma. B) Assess and deliver 4–8 mL/kg based on predicted body weight and
continuously assess cuff pressure to prevent VAP. C) Assess and deliver 4–8 mL/kg based on
predicted body weight, utilizing a manometer for intermittent cuff pressure assessment. D)
Deliver 6–8 mL/kg based on ideal body weight, utilizing telemonitoring exclusively to minimize
room entries.
● The Answer: C (Assess and deliver 4–8 mL/kg based on predicted body weight, utilizing a
manometer for intermittent cuff pressure assessment)
● Distractor Analysis:
○ A is incorrect: Using actual body weight in ARDS delivers massive, lethal volumes
leading to volutrauma, as lung size scales with height, not adiposity.
○ B is incorrect: While the VT parameters are correct, the 2024 AARC CPG explicitly
states that continuous cuff pressure assessment should NOT be implemented to
decrease the risk of Ventilator-Associated Pneumonia (VAP).
○ D is incorrect: The guidelines recommend direct bedside assessment rather than
telemonitoring when resources are adequate; telemonitoring is a supplement, not
an exclusive replacement.
The Mentor's Analysis: Lung-protective ventilation requires strict adherence to predicted body
weight formulas to bypass the common novice error of over-ventilating obese patients.
Furthermore, routine intermittent manometer checks remain the evidence-based standard over
continuous cuff monitors. Professional/Academic Intuition: Always scale VT to height via
predicted body weight, and abandon continuous cuff monitoring if the sole goal is VAP
reduction.
Q2: A 65-year-old mechanically ventilated patient is being evaluated for ventilator liberation. The
, attending physician requests a Rapid Shallow Breathing Index (RSBI) calculation before
initiating a Spontaneous Breathing Trial (SBT). According to the 2024 AARC CPG on SBTs,
what is the MOST APPROPRIATE response? A) Calculate the RSBI; if the value is less than
105, immediately initiate the SBT on continuous positive airway pressure (CPAP). B) Inform the
physician that RSBI calculation is not needed to determine SBT readiness, and initiate the SBT
using a standardized protocol. C) Calculate the RSBI and simultaneously increase the FiO2 by
10% to ensure adequate oxygenation during the transition. D) Delay the SBT until the late
afternoon to ensure the patient's neurocognitive status is optimal, bypassing the RSBI entirely.
● The Answer: B (Inform the physician that RSBI calculation is not needed to determine
SBT readiness, and initiate the SBT using a standardized protocol)
● Distractor Analysis:
○ A is incorrect: Relying on the legacy RSBI threshold (105) is an outdated
methodology; the 2024 guidelines definitively state RSBI calculation is no longer
necessary to dictate readiness.
○ C is incorrect: The 2024 AARC CPG explicitly mandates that FiO2 should NOT be
increased during an SBT, as this masks borderline pulmonary failure.
○ D is incorrect: The guidelines specifically suggest a standardized approach to
assessment and completion of an SBT before noon each day, not in the afternoon.
The Mentor's Analysis: The liberation phase demonstrates physiologic reserve, not the ability to
pass an isolated mathematical index. By abandoning the mandatory RSBI and refusing to
artificially inflate oxygen parameters, the clinician exposes the true ventilatory capacity of the
patient. Professional/Academic Intuition: Assess readiness early (before noon), eliminate the
RSBI prerequisite, and never artificially prop up oxygenation during a trial.
Q3: A 7-year-old child is admitted to the pediatric intensive care unit with status asthmaticus.
Based on the 2025 AARC/PALISI Clinical Practice Guideline for Pediatric Critical Asthma, which
initial pharmacological intervention is the MOST ACCURATE? A) Intermittent high-dose
nebulized short-acting beta-agonists (SABA) combined with intravenous methylxanthines. B)
Continuous inhaled SABA therapy and intravenous magnesium. C) Frequent intermittent SABA
therapy and application of heliox to bypass airway resistance. D) Continuous inhaled SABA
therapy and high-flow nasal cannula (HFNC) specifically to resolve impending hypercapnia.
● The Answer: B (Continuous inhaled SABA therapy and intravenous magnesium)
● Distractor Analysis:
○ A is incorrect: The 2025 guidelines cannot recommend for or against IV
methylxanthines; they represent a legacy theory largely abandoned due to narrow
therapeutic indices and high toxicity.
○ C is incorrect: Continuous SABA is heavily preferred over intermittent delivery.
Furthermore, the guideline cannot recommend for or against the use of heliox.
○ D is incorrect: HFNC provides oxygenation but does not reliably resolve
hypercapnia in critical asthma, and there is insufficient evidence to recommend
BiPAP over HFNC for pure distress.
The Mentor's Analysis: Pediatric critical asthma requires rapid, sustained bronchodilation and
smooth muscle relaxation. Continuous SABA paired with the calcium-channel blocking
properties of IV magnesium delivers a superior dual-mechanism approach to refractory
bronchospasm. Professional/Academic Intuition: In pediatric critical asthma, continuous
nebulization supersedes intermittent dosing, and IV magnesium is the supreme adjunct
over outdated methylxanthines.
Q4: A 62-year-old male with a history of COPD is evaluated in the pulmonary clinic. He reports
one moderate exacerbation in the past 11 months that required systemic corticosteroids, but no
